Medicines Development For Global Health

Medicines Development For Global Health company information, Employees & Contact Information

Medicines Development for Global Health (MDGH) develops medicines and vaccines for neglected diseases. Our approach is to bring together the ideas of researchers with our development expertise and passion to develop new products that will be life changing for millions. We are a not-for-profit pharmaceutical company - all funds in excess of expenses are devoted to this purpose. In June 2018 we received US FDA approval of moxidectin, the first new treatment for River Blindness in more than 30 years. Next we're turning our attention to seeing the benefit moxidectin might bring to other neglected tropical diseases and scabies. Read more at medicinesdevelopment.com Games to be changed. Much work to do. Sign up for our quarterly newsletter here: https://bit.ly/3mwzi0N

Company Details

Employees
36
Founded
-
Address
Level 1, 18 Kavanagh St, Southbank,australia
Phone
+61 3 9629 6111
Email
in****@****ent.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Melbourne, VIC
Looking for a particular Medicines Development For Global Health employee's phone or email?

Medicines Development For Global Health Questions

News

Quality by digital design to accelerate sustainable medicines development - ScienceDirect.com

Quality by digital design to accelerate sustainable medicines development ScienceDirect.com

Medicare Drug Price Negotiation has Chilling Effect on Generic and Biosimilar Medicines Development and Availability - Association for Accessible Medicines

Medicare Drug Price Negotiation has Chilling Effect on Generic and Biosimilar Medicines Development and Availability Association for Accessible Medicines

European Federation for Exploratory Medicines Development Lyon Conference 2019: The Changing Landscape of Early Medicines Development—Be Prepared - Frontiers

European Federation for Exploratory Medicines Development Lyon Conference 2019: The Changing Landscape of Early Medicines Development—Be Prepared Frontiers

Moderna and Generation Bio partner for genetic medicines development - Pharmaceutical Technology

Moderna and Generation Bio partner for genetic medicines development Pharmaceutical Technology

Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond - Frontiers

Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond Frontiers

New £8.2M MRC Medicines Development Fellowship Programme announced - The University of Manchester

New £8.2M MRC Medicines Development Fellowship Programme announced The University of Manchester

University leads new £8.2M medicines development fellowship programme - University of Liverpool

University leads new £8.2M medicines development fellowship programme University of Liverpool

AstraZeneca expands Global Medicines Development centre in India - BioSpectrum India

AstraZeneca expands Global Medicines Development centre in India BioSpectrum India

Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU - Frontiers

Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU Frontiers

MHRA Innovative Medicines Symposium - supporting innovative medicines development - GOV.UK

MHRA Innovative Medicines Symposium - supporting innovative medicines development GOV.UK

AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer - Cision News

AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer Cision News

The International Medicines Development Course – 2015 – Semmelweis University - Semmelweis Egyetem

The International Medicines Development Course – 2015 – Semmelweis University Semmelweis Egyetem

Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature - Frontiers

Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature Frontiers

Editorial: Grand Challenges in Pharmaceutical Medicine: Competencies and Ethics in Medicines Development - Frontiers

Editorial: Grand Challenges in Pharmaceutical Medicine: Competencies and Ethics in Medicines Development Frontiers

Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York - Frontiers

Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York Frontiers

Utilization of genetic information for medicines development and equitable benefit sharing - Frontiers

Utilization of genetic information for medicines development and equitable benefit sharing Frontiers

Top Medicines Development For Global Health Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant